ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

Applications Pour In for construction Grants; Three Compete For Mouse Laboratory

June 1, 1990

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001